If you need a customized product, please contact us!
Broad-Spectrum Antibacterial Activity: Rifampicin is a broad-spectrum rifamycin antibiotic effective against Mycobacterium tuberculosis, Gram-positive bacteria, Gram-negative bacteria, and certain viruses.
Strong Anti-Tuberculosis Efficacy: It provides a powerful antibacterial effect against tuberculosis bacteria, making it a core agent in anti-TB therapy.
Synergistic Combination Therapy: When used in combination with other anti-tuberculosis drugs, it delivers a synergistic therapeutic effect, improving overall treatment outcomes.
Helps Delay Drug Resistance: Combination use can effectively delay the development of drug-resistant strains, supporting long-term clinical efficacy.
Product Description of Rifampicin CAS#13292-46-1
Rifampicin is a broad-spectrum rifamycin antibiotic. It strongly acts on tubercle bacilli, various gram-positive, gram-negative bacteria and partial viruses.
It is red crystalline powder insoluble in water, mainly made into oral dosage forms. Combined with other anti-tuberculosis drugs, it produces synergistic effects and delays drug resistance, serving as a core drug for tuberculosis therapy.
Product Application of Rifampicin CAS#13292-46-1
Rifampicin is a broad-spectrum, cell-penetrating bactericidal antibiotic active against Mycobacterium tuberculosis, Gram-positive and some Gram-negative bacteria. It is mainly used to treat drug-resistant tuberculosis, drug-resistant Staphylococcus aureus infections and leprosy. It also serves as a pharmaceutical intermediate with the same antibacterial spectrum, showing good efficacy against Gram-positive cocci and Mycobacterium tuberculosis.
We provide the best products.
If you have any questions or need assistance, please feel free to contact us. We are committed to providing you with excellent service and ensuring your satisfaction.
Send Us Your Inquiry Today

INEOS Chemical is a professional chemical product supplier with ample stock of all chemical categories and excellent quality, welcome your purchase inquiry.

